San-El Mühendislik Acquires 50% Stake in Uşakcan Diyaliz

San-El Mühendislik Elektrik Sanayi ve Ticaret A.Ş. announced via the Public Disclosure Platform (KAP) that its subsidiary Salacak Sağlık Yatırımları A.Ş. has signed an agreement to acquire a 50% stake in Uşakcan Diyaliz Hizmetleri A.Ş. According to the company's statement, the total consideration for the share transfer is set at 74 million Turkish Lira. This transaction is part of San-El Mühendislik's strategy to expand its investments in the healthcare sector. Through this acquisition, Salacak Sağlık Yatırımları has obtained a significant partnership stake in Uşakcan Diyaliz, which operates in the dialysis services field. The necessary legal procedures for the completion of the share transfer are expected to be finalized shortly. San-El Mühendislik anticipates that this investment will contribute to the company's growth targets and strengthen its presence in the healthcare sector. This is not investment advice.

📊 SANEL — Piyasa Yorumu

■ neutral · 60%

While the news is positive for the company's growth strategy, the recent decline in the stock price and mixed signals from technical indicators make it difficult to determine a clear direction in the short term. The RSI remains balanced at the 50 level, while the MACD line is just below the signal line, indicating a weak bearish trend. The price being below the 20- and 50-day moving averages confirms short-term pressure. Therefore, the positive impact of the news may offset the technical weakness, and the price is expected to trade sideways for a while.

RSI 14

50.2

MACD

0.75

24h Δ

-4.94%

Canlı Grafikler